Filing Details

Accession Number:
0001209191-19-008847
Form Type:
5
Zero Holdings:
No
Publication Time:
2019-02-11 13:23:53
Reporting Period:
2018-12-31
Accepted Time:
2019-02-11 13:23:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1649904 Rhythm Pharmaceuticals Inc. RYTM () 5
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1473930 Todd Foley C/O Mpm Asset Management
450 Kendall Street
Cambridge MA 02142
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-06-25 378,501 $26.42 3,074,893 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Footnotes
  1. The shares are were purchased as follows: 364,347 by MPM BioVentures V, L.P. ("BV V") and 14,154 by MPM Asset Management Investors BV5 LLC ("AM BV5"). MPM BioVentures V GP LLC and MPM BioVentures V LLC ("BV LLC") are the direct and indirect general partners of BV V. Ansbert Gadicke, Luke Evnin and Todd Foley are the members of BV LLC. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
  2. Shares are held as follows: 2,959,906 by BV V and 114,987 by AM BV5. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.